Welcome to our dedicated page for Nature’S Sun SEC filings (Ticker: NATR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. SEC filings for Nature’s Sunshine Products, Inc. (NASDAQ: NATR), a natural health and wellness company that manufactures and distributes herbal, nutritional and personal care products. As a registrant on the Nasdaq Capital Market, Nature’s Sunshine files periodic and current reports that describe its operations, financial condition, risk factors and material corporate events.
Through this filings feed, readers can review annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically include segment information for Asia, Europe, North America and Latin America & Other, along with discussions of gross margins, selling, general and administrative expenses, adjusted EBITDA and the impact of foreign currency. These reports also incorporate detailed risk factor disclosures related to government regulation, direct selling, independent consultants, product liability, supply chain disruptions, cybersecurity, data privacy and tax matters.
Nature’s Sunshine also uses current reports on Form 8-K to announce material events. Recent 8-K filings have covered quarterly financial results, executive leadership changes such as the appointment of a new Chief Executive Officer, secondary public offerings by a selling stockholder, share repurchase agreements, and share purchase agreements to acquire interests in joint ventures in Hong Kong and Shanghai. These filings often reference non-GAAP measures and include reconciliations in attached exhibits.
Investors can also monitor registration statements and prospectus supplements related to offerings of common stock, as well as agreements tied to concurrent share repurchases. Where applicable, Form 4 and other insider transaction reports provide additional insight into trading activity by directors and officers.
On Stock Titan, AI-powered tools summarize lengthy filings, highlight key changes from prior periods and surface important items such as segment performance, capital allocation decisions, material contracts and governance updates. Real-time ingestion from EDGAR helps ensure that new NATR filings, including 10-Ks, 10-Qs, 8-Ks and ownership reports, are available quickly with plain-language explanations to support deeper research into Nature’s Sunshine’s regulatory and financial disclosures.
Natures Sunshine Products EVP and General Counsel Nathan G. Brower reported routine equity compensation activity. He acquired 1,086 common shares through an exercise of derivative securities and then had 371 shares withheld at $25.06 per share to cover taxes on vesting.
Brower also received a grant of 7,250 restricted stock units at a reference price of $25.06. These RSUs vest in three equal annual installments through March 6, 2029. A prior performance-based RSU grant vested after the company achieved an adjusted EBITDA milestone of $48M over a rolling 12‑month period. Following these transactions, he directly holds 53,200 common shares.
NATURE'S SUNSHINE PRODUCTS (NATR) executive compensation moves: EVP & President, North America Kevin R. Herbert reported multiple equity-related transactions in common shares on March 6, 2026.
He acquired 1,239 common shares through an exercise or conversion tied to a performance-based restricted stock unit grant that vested after the company achieved an adjusted EBITDA milestone of $48M over a rolling 12‑month period. Upon meeting this target, half of the award vested, with the remaining half scheduled to vest one year after that milestone.
The company withheld 368 shares, valued using a $25.06 closing price, to cover taxes due at vesting, a non-market, tax-withholding disposition rather than an open-market sale. Herbert also received a new grant of 7,124 restricted stock units at a reference price of $25.06 per share, which will vest in three equal annual installments through March 6, 2029. Following these transactions, he directly holds 50,610 common shares.
Natures Sunshine Products EVP & Chief Financial Officer Leslie Shane Jones reported equity compensation activity in company common shares. Jones received 2,002 vested shares tied to achieving a $48M adjusted EBITDA milestone over a rolling 12-month period and had 878 shares withheld at $25.06 per share to cover taxes on vesting. Jones was also granted 11,798 restricted stock units, each representing one common share, which vest in three equal annual installments through March 6, 2029, bringing direct holdings to 121,514 common shares.
Natures Sunshine Products senior vice president and chief accounting officer Jonathan David Lanoy reported compensation-related equity activity in company common shares. He exercised derivative awards to acquire 913 shares and had 312 shares withheld at $25.06 per share to cover taxes on vesting, with no open-market sale. He also received a grant of 5,415 restricted stock units, each equal to one common share, which vest in three equal annual installments through March 6, 2029. A portion of his shares vested after the company achieved an adjusted EBITDA milestone of $48M over a rolling 12-month period, and he now directly holds 52,249 common shares.
Natures Sunshine Products EVP & President, Asia Daniel C. Norman reported compensation-related share activity. He acquired 1,541 Common Shares on March 6, 2026 through the vesting of performance-based restricted stock units tied to an adjusted EBITDA milestone of $48M over a rolling 12‑month period.
On the same date, 527 Common Shares were withheld at $25.06 per share to cover taxes due at vesting, a non-market disposition. He also received a grant of 10,088 restricted stock units, each representing one NATR share, vesting in three equal annual installments through March 6, 2029. Following these transactions, he directly holds 64,079 Common Shares, with additional equity exposure through the new RSU grant.
Natures Sunshine Products EVP & President, Europe Bryant J. Yates reported compensation-related share activity in Common Shares. On March 6, he received 7,761 restricted stock units (RSUs) at a reference price of $25.06 per share, which will vest in three equal annual installments through March 6, 2029. He also acquired 1,317 vested shares tied to achieving an adjusted EBITDA milestone of $48M over a rolling 12‑month period under a March 11, 2024 performance-based RSU grant. To cover taxes upon vesting, 450 shares were withheld at $25.06 per share, a non‑market tax-withholding disposition. After these transactions, Yates directly holds 107,232 Common Shares.
Romanzi Kenneth G. reported acquisition or exercise transactions in this Form 4 filing.
NATURES SUNSHINE PRODUCTS INC reported that Chief Executive Officer Kenneth G. Romanzi received a grant of 29,928 common-share-equivalent restricted stock units at a reference price of $25.06 per share. Following this award, he directly holds 132,809 common shares.
The RSUs were granted under his employment agreement dated October 10, 2025 and vest in three equal annual installments from the initial grant date through March 6, 2029, with each RSU representing the right to receive one NATR common share.
Fritz Erich A reported acquisition or exercise transactions in this Form 4 filing.
Natures Sunshine Products executive Fritz Erich, EVP of Global Supply Chain, received a grant of 8,180 common shares in the form of restricted stock units at a reference price of $25.06 per share. Each RSU represents one share of common stock and vests in three equal annual installments through March 6, 2029. Following this compensation grant, Erich directly holds 18,940 common shares, reflecting his ongoing equity stake in the company.
Fuller Kevin Gregory reported acquisition or exercise transactions in this Form 4 filing.
NATURES SUNSHINE PRODUCTS INC granted Global Chief Marketing Officer Kevin Gregory Fuller 7,965 common shares in the form of restricted stock units at an indicated value of $25.06 per share. The RSUs vest in three equal annual installments from the initial grant date through March 6, 2029, bringing his direct holdings to 30,922 shares.